Viagra vs. Cialis: Little Blue Pill Is Losing Big

Dec. 19 (Bloomberg) -- Bloomberg's Eric Chemi take a look at the two most popular erectile dysfunction medications on the market, Viagra and Cialis. Pfizer, the maker of Viagra, eliminated 20% of its sales workforce on December 18.

KKR’s McVey Says Macron Embraced as Anti-Establishment
15:29 - Henry McVey, head of macro & asset allocation and CIO of balance sheet at KKR, discusses elections in France and the outlook for EU markets overall. He speaks with Bloomberg's Erik Schatzker on "Bloomberg Markets." (Source: Bloomberg)
  • Why Would LVMH Buy Christian Dior Couture?
  • Where Does the U.K. Labour Party Stand on Brexit?
  • QuickTake: Why the Swiss Love Referendums